Acadia Healthcare (NASDAQ:ACHC) Downgraded by StockNews.com to “Sell”

StockNews.com downgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a sell rating in a research report report published on Monday morning.

Several other research analysts also recently weighed in on ACHC. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and upped their target price for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Royal Bank of Canada decreased their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Barclays reduced their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $73.38.

Acadia Healthcare Price Performance

Shares of ACHC opened at $44.85 on Monday. The company has a market capitalization of $4.17 billion, a P/E ratio of 14.70, a P/E/G ratio of 1.77 and a beta of 1.29. The business’s 50-day moving average is $40.70 and its two-hundred day moving average is $58.54. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare has a fifty-two week low of $36.50 and a fifty-two week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same period in the previous year, the business posted $0.91 EPS. The business’s revenue was up 8.7% compared to the same quarter last year. Research analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Wellington Management Group LLP raised its stake in Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares during the period. William Blair Investment Management LLC lifted its holdings in Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after acquiring an additional 604,070 shares during the last quarter. JPMorgan Chase & Co. grew its position in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after acquiring an additional 454,044 shares during the period. State Street Corp increased its stake in Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after acquiring an additional 95,613 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its stake in shares of Acadia Healthcare by 0.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock valued at $144,753,000 after purchasing an additional 12,470 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.